Literature DB >> 33895782

Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2.

Lihong Huang1,2, Terrence Tsz-Tai Yuen3, Zuodong Ye1,2, Shuyan Liu4, Guoliang Zhang4, Hin Chu5, Jianbo Yue6,7.   

Abstract

Entities:  

Year:  2021        PMID： 33895782     DOI： 10.1038/s41392-021-00584-6

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  6 in total

1.  Computational studies evidenced the potential of steroidal lactone to disrupt surface interaction of SARS-CoV-2 spike protein and hACE2.

Authors:  Ajay Yadav; Monu Dinesh Ojha; P Hariprasad
Journal:  Comput Biol Med       Date:  2022-05-13       Impact factor: 6.698

2.  Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection.

Authors:  Prabhakaran Kumar; Manikannan Mathayan; Sandra P Smieszek; Bartlomiej P Przychodzen; Vuk Koprivica; Gunther Birznieks; Mihael H Polymeropoulos; Bellur S Prabhakar
Journal:  Virology       Date:  2022-05-16       Impact factor: 3.513

3.  Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion.

Authors:  Zhe-Rui Zhang; Ya-Nan Zhang; Hong-Qing Zhang; Qiu-Yan Zhang; Na Li; Qi Li; Cheng-Lin Deng; Bo Zhang; Xiao-Dan Li; Han-Qing Ye
Journal:  PLoS Negl Trop Dis       Date:  2022-04-25

4.  A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon.

Authors:  Na Li; Xiao-Ling Chen; Qi Li; Zhe-Rui Zhang; Cheng-Lin Deng; Bo Zhang; Xiao-Dan Li; Han-Qing Ye
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 5.  Autophagy in SARS-CoV-2 infection.

Authors:  Di Chen; Hong Zhang
Journal:  Curr Opin Physiol       Date:  2022-09-27

6.  In vitro inhibition of SARS-CoV-2 Infection by dry algae powders.

Authors:  Daniel Garcia-Ruiz; Erendira Villalobos-Sánchez; David Alam-Escamilla; Darwin Elizondo-Quiroga
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.